The arrival of Retatrutide ZPHC, at a concentration of 120mg, is sparking considerable buzz within the weight loss community. This innovative dual GIP and GLP-1 receptor medication suggests to offer impressive improvements in weight shedding compared to current therapies. Preliminary research tri